New drug PRX019 takes first step: safety check in healthy people

NCT ID NCT06699680

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tested a new drug, PRX019, in 50 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo, and researchers monitored for side effects and measured drug levels in the blood. Since this is a first-in-human study, the main goal is gathering safety information, not treating any illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PRX019

What could go wrong

This is a very early, first-in-human study with only 50 healthy participants. It is designed to check safety, not to treat any disease, so there is no guarantee the drug will work for any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Local Institution

    Los Alamitos, California, 90720, United States